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Abstract Children with congenital heart disease (CHD)
who survive surgery often present impaired neurode-
velopment and qualitative brain anomalies. However,
the impact of CHD on total or regional brain volumes
only received little attention. We address this question
in a sample of patients with 22q11.2 deletion syndrome
(22q11DS), a neurogenetic condition frequently asso-
ciated with CHD. Sixty-one children, adolescents, and
young adults with confirmed 22q11.2 deletion were
included, as well as 80 healthy participants matched for
age and gender. Subsequent subdivision of the patients
group according to CHD yielded a subgroup of 27
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patients with normal cardiac status and a subgroup
of 26 patients who underwent cardiac surgery during
their first years of life (eight patients with unclear
status were excluded). Regional cortical volumes were
extracted using an automated method and the associa-
tion between regional cortical volumes, and CHD was
examined within a three-condition fixed factor. Robust
protection against type I error used Bonferroni correc-
tion. Smaller total cerebral volumes were observed in
patients with CHD compared to both patients without
CHD and controls. The pattern of bilateral regional re-
ductions associated with CHD encompassed the supe-
rior parietal region, the precuneus, the fusiform gyrus,
and the anterior cingulate cortex. Within patients, a
significant reduction in the left parahippocampal, the
right middle temporal, and the left superior frontal
gyri was associated with CHD. The present results of
global and regional volumetric reductions suggest a role
for disturbed hemodynamic in the pathophysiology of
brain alterations in patients with neurodevelopmental
disease and cardiac malformations.
Keywords Velocardiofacial · Cardiac surgery ·
Neuroimaging · FreeSurfer
Introduction
Congenital heart diseases (CHD) are among the most
frequent birth defects. Over the past few decades,
progress in surgical techniques has allowed for the cor-
rection of most CHD, so that an increasing number of
children and adults live with surgically corrected CHD
(Wernovsky et al. 2005). Nevertheless, CHD and its
correction still have neurological and developmental
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costs (Wray 2006). Survivors often present difficulties
in expressive language, visuomotor skills, and fine
motor function (Bellinger et al. 1999), as well as inat-
tention and hyperactivity (Shillingford et al. 2008).
Non-specific structural brain anomalies associated with
these impairments have been reported, which include
microcephaly, abnormalities of the cortical mantle
(Glauser et al. 1990), and frequent periventricular
leukomalacia (Gaynor 2004). The pathophysiology of
brain anomalies associated with CHD has largely in-
criminated intraoperative support mechanisms, lead-
ing to continuous improvement of surgical procedures
(Nelson et al. 2008). But more recently, it has also
been evidenced that neurological abnormalities, such as
microcephaly or leukomalacia, may be present before
surgery (Limperopoulos et al. 1999; Mahle et al. 2002;
Miller et al. 2007). As reduced cerebral blood flow
has been shown in fetuses (Donofrio et al. 2003) and
neonates with complex CHD (Licht et al. 2004), presur-
gical brain abnormalities may be the consequence of
decreased perfusion pressure in the developing brain.
Despite increasing evidence that reduced blood per-
fusion impairs brain growth in individuals with CHD,
the quantification of cerebral volumes in children or
adult survivors only received little attention. Further,
the question as to how cerebral volume may be altered
regionally in survivors remained similarly unaddressed.
If we look at brain anomalies related to CHD from
another point of view, we cannot ignore the numer-
ous neurogenetic conditions frequently associated with
CHD in which abnormalities of the brain structure are
well documented, such as Williams syndrome, Down
syndrome, or 22q11.2 deletion syndrome (22q11DS;
Meyer-Lindenberg et al. 2006; Schaer and Eliez 2007;
Teipel and Hampel 2006; Gothelf et al. 2008; Martens
et al. 2008). Among neurogenetic syndromes, the one
with the strongest association with CHD is probably
22q11DS. Prospective studies of neonates with CHD
have shown that deletion at 22q11.2 accounts for one
third of patients with conotruncal heart defect (most
often tetralogy of Fallot and truncus arteriosus) and
one half of patients with interrupted aortic arch (Hay
2007). Moreover, 50% to 75% of patients with 22q11DS
have CHD (McDonald-McGinn et al. 1999; Ryan et al.
1997). In addition, to a strong bidirectional associa-
tion between CHD and 22q11DS, striking similarities
in the difficulties presented by children affected with
22q11DS and children with CHD have led to the sug-
gestion that part of the cognitive or cerebral phenotype
in 22q11DS may be caused by CHD (Wernovsky et al.
2005). Specifically, children with 22q11DS show visu-
ospatial impairments, fine motor difficulties, executive
dysfunction, and frequent attention problems (Gerdes
et al. 1999; Swillen et al. 1999), all of which are com-
monly seen in non-syndromic patients with CHD. Al-
though patients with 22q11DS and CHD demonstrate
more severe intellectual impairments than patients with
CHD alone (Atallah et al. 2007), comparing children
with 22q11DS but with and without CHD offers an
interesting framework to study the effect of CHD on
brain structure and cognition. To date, no study has
observed any differences in the cognitive outcome of
children with 22q11DS with and without CHD (Gerdes
et al. 1999; Simon et al. 2002; Bearden et al. 2001;
Swillen et al. 1997; De Smedt et al. 2007). Similarly, pre-
vious neuroimaging studies grouping participants with
widely varying CHD did not evidence any significant
difference in brain morphology (Bearden et al. 2007;
Bingham et al. 1997; Kates et al. 2001). However, using
cardiac surgery as a strict clinical criteria, we previously
observed a significantly reduced degree of cortical fold-
ing associated with CHD in patients with 22q11DS
(Schaer et al. 2009), which suggests that the most severe
cardiac anomalies affect early brain development in
22q11DS. In the present study, we address the question
of regional volumetric reductions associated with CHD
using a recent method that measure gyral volumes
across the brain (Desikan et al. 2006). First, we quantify
volumetric reductions that are specific to the syndrome
by comparing patients to controls. Then, we identify
the regions that are specifically altered in patients with
surgically corrected CHD compared to patients without
CHD.
Materials and methods
Participants
Individuals with 22q11DS
Sixty-one individuals with 22q11.2 deletion syndrome
participated in the current study. The sample consisted
of children, adolescents, and young adults, with an
average age of 15.6 ± 8.9 (36 females, 25 males). Pa-
tients had an average IQ of 68.7 ± 12.0. Participants
were recruited through announcements to regional par-
ent associations. All individuals were native French-
or English-speaking individuals and were assessed in
their native language. Only children with a confirmed
22q11.2 deletion were included in the study. Aside
from the large prevalence of cardiac malformations
presented below, the 61 patients also presented a vari-
ety of medical comorbidities known to be commonly as-
sociated with the syndrome. Facial dysmorphic features
and palate or pharyngeal malformations were highly
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prevalent (including 25 patients requiring corrective
surgery); a large proportion of patients suffered from
endocrine disorders including hypoparathyroidism or
repeated infections due to thymic hypoplasia; three
patients had unilateral renal agenesis. At the psychi-
atric level, 19 of the 61 patients presented halluci-
nations (nine females/ten males, average age 22.5 ±
7.5), 17 delusions (eight females/nine males, average
age 22.0 ± 9.4), and five met the DSM-IV criteria for
schizophrenia (two females/three males, average age
31.2 ± 4.5). At the time of their participation, eight
patients were taking psychotropic medications (four
females/four males, average age 27.7 ± 8.2) and three
were taking antiepileptic medications (two females/one
male, average age 23.1 ± 11.3).
Cardiac malformations in 22q11DS
A history of cardiac surgery was documented using
a questionnaire to the parents. In addition, medical
reports, including ultrasound examinations and surgical
reports, were examined. Twenty-seven patients with
major cardiac defects were identified and constituted
the CHD subgroup (17 females/ten males, mean age
13.7 ± 8.3). The type of CHD and the age at cardiac
surgery are detailed for each patient in Table 1. Eight
patients were excluded at analysis for unclear cardiac
status (two with retroesophageal subclavian artery, six
with documented interventricular communication with
spontaneous closure at follow-up). Twenty-six patients
with normal heart, or with benign heart murmurs at
birth with normal ultrasound examination, were in-
cluded in the noCHD subgroup (13 females/13 males,
mean age 17.6 ± 9.8). Although the age difference be-
tween the CHD and noCHD subgroups did not reach
significance (p = 0.121), age was covaried out in all
statistical analyses.
IQ scores in the subgroup of patients with CHD
(66.7 ± 12.6) did not differ from IQ in the subgroup
without (70.0 ± 11.6, p = 0.333), neither did PIQ (p =
0.365) nor VIQ (p = 0.364). In further exploratory
statistics, we subdivided all patients who we included
in the CHD analyses (n = 53) into two subgroups of
equal size according to their IQ performances. The low
performing subgroup (FSIQ ≤ 67) was composed of
26 patients with an average IQ of 58.2 ± 6.7 (mean age
17.3 ± 9.5), and the high performing subgroup (FSIQ ≥
68) was composed of 27 patients with an average IQ
of 78.1 ± 7.0 (mean age 14.1 ± 8.8). The proportion
of low-performing patients in the CHD subgroup (17
out of 27, 65.4%) was significantly higher than the
proportion of low-performing patients in the no-CHD
subgroup (nine out of 26, 34.6%, p = 0.039, φ = 0.283).
Table 1 Description of the subgroups with 22q11DS according
to a history of major congenital cardiac malformation and subse-
quent surgery
Age Sex CHD Age at cardiac surgery
6.1 F ASD, VSD 3 months
6.1 M PHT, VSD 3 months
6.3 F PAH, VSD Surgery planned
6.3 M IAA, ASD, VSD 1 and 3 months
6.4 M ToF 5 months
7.0 F IAA, VSD 1 month
7.3 F TA, VSD 1 month
7.6 M PA-VSD (ToF) 11 days
7.6 F ASD, VSD 6 months
7.9 F ToF 15 months
8.0 F PA-VSD (ToF) 2 months and 3.5 years
8.6 F ASD, VSD 5 months
10.9 F ASD, VSD 8 months
11.2 F IAA, VSD 8 days
11.9 M IAA, VSD 9 days and 4 years
12.5 M ToF 3 years
13.3 M ToF 2.5 years
14.3 F ToF 2 years
14.6 F ToF 1 year
17.7 F Unspecified 4 and 14 years
18.1 M IAA, VSD At birth and 1 year
19.6 F IAA, VSD 4 days and 3 months
21.6 M ToF 17 months
23.3 M Aortic dysplasia During 1st year
30.0 F ToF 3 and 5 years
32.5 F ASD During 1st year
33.4 F PAH, VSD 11 years
F female, M male, ToF tetralogy of fallot, VSD ventricular septal
defect, ASD atrial septal defect, IAA interrupted aortic arch,
PAH pulmonary artery hypoplasia, PA-VSD pulmonary atresia
with ventricular septal defect (often considered to be the most
severe of the ToF defects), PHT pulmonary hypertension, TA
truncus arteriosus
This difference appeared mainly driven by the adoles-
cents and adults with CHD, as the nine patients with
CHD who were older than 14 years old were all low
performers.
Among the patients with hallucinations, the propor-
tion of patients with CHD (six out of 27) did not sig-
nificantly differ from the proportion of patients without
(nine out of 26, p = 0.372, φ = −0.138; four patients
with hallucinations were not included in the cardiac
analyses because of their unclear cardiac status). The
proportion of patients with CHD and delusions (five
out of 27) did not significantly differ from the propor-
tion of patients with delusions and without CHD (11
out of 26, p = 0.077, φ = −0.259; one patient with delu-
sion and unclear cardiac status). Finally, the proportion
of patients with schizophrenia and CHD (two out of
27) did not significantly differ from the proportion of
patients with schizophrenia and without CHD (two out
of 26, p = 1.0, φ = −0.005).
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Control group
The comparison group was comprised of 80 typically
developing individuals (44 females, 36 males). The con-
trol group had an average age of 15.9 ± 8.4 and an
average IQ of 111.7 ± 12. Individuals were recruited
through a newsletter distributed at public schools and
in the Geneva community. A complete medical history,
as well as parent report (CBCL in children and ado-
lescents; Achenbach 1991) and self-report (SCL-90R
in adolescents and adults; Derogatis 1983) behavioral
questionnaires were used to screen control participants.
Subjects with a history of past or present neurolog-
ical or psychiatric disorders were excluded. Written
informed consent was received from all subjects, as well
as the parents of subjects younger than 18 years of age,
in accordance with protocols approved by the Institu-
tional Review Board of Geneva University School of
Medicine.
MRI acquisition and processing
Cerebral magnetic resonance images were acquired
with a T1-weighted 3D volumetric pulse sequence us-
ing a Philips Intera 1.5-T scanner as a series of 124
contiguous coronal slices, with a voxel size of 0.9375 ×
0.9375 × 1.5 mm (TR = 35 ms, TE = 6 ms, flip angle =
45◦, NEX = 1).
Cortical reconstruction and volumetric segmentation
were performed using published algorithms included in
FreeSurfer software (Harvard University; Dale et al.
1999; Fischl et al. 2001). Briefly, processing consisted
of removal of non-brain tissue (Sgonne et al. 2004),
automatic segmentation of the subcortical gray matter
structures (Fischl et al. 2002), and the extraction of
cortical surfaces, which was performed according to
previously published protocols (Dale et al. 1999; Fischl
and Dale 2000). Both intensity and continuity informa-
tion from the entire three-dimensional MR volume are
used in segmentation and deformation procedures, thus
producing accurate representation of cortical thickness
or volumes. These procedures have been validated
against histological studies (Rosas et al. 2002), manual
measurements (Kuperberg et al. 2003; Salat et al. 2004),
and shown reliable across scanner manufacturers and
field strengths (Han et al. 2006).
Subsequent to cortical reconstruction, the cortex is
subdivided into units based on gyral and sulcal struc-
tures (Desikan et al. 2006). This parcellation method
based on major sulci has been shown to be both valid
and reliable, with high intraclass correlation coefficient
between the manual and automated procedures for
both cortical volume estimates and parcel boundaries.
The parcellation produces 34 gyral regions subdivided
into 11 frontal regions, nine temporal regions, five
parietal regions, four occipital regions, four parts of the
cingulate cortex, and finally the corpus callosum which
is designed to improve the reliability of the placement
of the other parcels (for details, please refer to the
validation article; Desikan et al. 2006). In the present
study, the frontal pole and the banks of the superior
temporal sulcus regions that exhibited relatively poor
reliability in the validation article were excluded from
statistical analyses. Cortical volume was therefore es-
timated for 31 parcels in each hemisphere for each
subject.
Statistical analyses
Patients vs controls
ANOVA was used to compare total cerebral volume
between groups. Subsequent MANCOVA compared
the 31 ROIs in each hemisphere with diagnosis as the
fixed factor and both age and total cerebral volume as
covariates. Results are reported both with a statistical
threshold of p < 0.05 and with a Bonferroni’s corrected
threshold of p < 0.0016.
Patients with and without CHD
In order to test whether volumetric alterations were
associated with CHD, we then conducted the same
MANCOVA on the 31 parcels in each hemisphere,
using age and total cerebral volume, but with three
conditions as our fixed factor (control, patient with
CHD, patient without CHD). IQ was not included as
a covariate in the model, as it was not a significant pre-
dictor of the model (left: p = 0.955; right: p = 0.545).
Parcels that were significant at p < 0.05 were further
tested in pairs using a Scheffe post hoc on cortical
volumes residualized for age. Post hoc results are also
reported at p < 0.05 and p < 0.0016.
In order to assess the specificity of cardiac malfor-
mations or surgery against other type of malforma-
tions or surgery, we also compared total and regional
cerebral volumes between the 25 patients who under-
went palate or pharyngeal surgery (14 females/
11 males, average age 17.0 ± 9.6) and the 36 patients
without (22 females/14 males, average age 14.7 ± 8.4).
Of note, the presence of severe palate or pharyngeal
malformations was not associated with the presence of
CHD in our sample of patients (11 of the 16 patients
without CHD and ten of the 27 patients with CHD
underwent palate or pharyngeal surgery).
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Results
Patients vs controls
A 12.4% reduction in cerebral volume was observed
in patients with 22q11DS compared to controls (see
Table 2), the regional distribution of which is further
depicted in Fig. 1. Specifically, Fig. 1 demonstrated that
cortical reductions seen in 22q11DS were the largest in
the posterior and medial parts of the brain.
Detailed statistical significance reported in Table 2
confirms the pattern of cortical alteration visible in
Fig. 1. Significantly preserved (i.e., relatively increased)
cortical regions in the syndrome are exclusively located
in the frontal lobes. Posterior regions with the greatest
reduction in 22q11DS reach almost equal significance
in both hemispheres, at the precuneus, fusiform gyrus,
and the most anterior part of the cingulate cortex.
Widespread reductions are also observed in the pari-
etal and occipital lobes, although these did not reach
significance after correcting for the number of tests.
Patients with and without CHD
We observed a prominent association between con-
genital heart disease and reduced total and regional
cerebral volumes. While patients with 22q11DS and
normal cardiac status showed a 6.9% reduction in total
cerebral volume compared to controls, patients who
underwent cardiac surgery had an average of 16.9%
reduction. Statistical significance in Table 3 demon-
strates two patterns of cortical changes in patients with
Table 2 Regional cortical volumetric changes in patients with 22q11DS compared to controls
Control 22q11DS F p
Total cerebral volumea 1,072,287 (101,804) 939,831 (114,254) 52.7 <0.001
Cortical regions showing relative preservation in 22q11DS
Left Lateral orbitofrontal 8,227.3 (983.6) 8,055.4 (1,162.2) 20.4 <0.001
Pars opercularis 5,176.7 (925.3) 5,242.4 (984.8) 6.0 0.016
Precentral 14,684.5 (1,575.4) 14,188.6 (1,841.1) 5.7 0.019
Pars orbitalis 2,743.0 (456.8) 2,628.7 (591.3) 5.7 0.019
Superior frontal 27,430.5 (3,653.1) 25,494.9 (3,990.5) 4.8 0.030
Medial orbitofrontal 5,106.4 (880.8) 4,955.8 (787.7) 4.3 0.041
Right Precentral 14,493.0 (1,806.5) 14,117.5 (2,006.4) 15.0 <0.001
Superior frontal 25,605.5 (3,313.5) 24,819.5 (3,713.7) 13.5 <0.001
Lateral orbitofrontal 8,273.2 (954.5) 7,901.0 (1,381.6) 12.2 <0.001
Pars orbitalis 3,196.3 (630.0) 3,097.5 (659.3) 5.3 0.023
Cortical regions showing disproportionate reductions in 22q11DS
Left Precuneus 11,187.8 (1,633.8) 9,164.4 (1,705.3) 23.3 <0.001
Fusiform 10,379.1 (1,443.6) 8,413.5 (1,534.4) 16.8 <0.001
Rostral ant. cingulate 2,701.1 (600.7) 2,025.7 (471.3) 12.7 <0.001
Temporal pole 2,672.6 (500.4) 2,278.3 (419.0) 11.4 <0.001
Cuneus 3,356.7 (686.1) 2,636.8 (536.5) 9.4 0.003
Superior parietal 14,728.9 (2,562.2) 12,750.4 (2,058.1) 7.3 0.008
Caudal ant. cingulate 2,031.5 (583.1) 1,567.9 (315.5) 6.8 0.010
Pericalcarine 2,258.7 (514.7) 1,754.0 (426.1) 4.2 0.041
Right Precuneus 11,452.6 (1,967.0) 9,418.3 (1,472.7) 19.6 <0.001
Lingual 7,545.5 (1,292.4) 6,122.9 (954.0) 13.5 <0.001
Rostral ant. cingulate 2,123.5 (430.2) 1,658.0 (383.2) 13.4 <0.001
Fusiform 9,628.3 (1,430.3) 7,628.4 (1,732.7) 11.8 <0.001
Cuneus 3,860.5 (791.1) 3,118.3 (672.2) 5.8 0.017
Rostral middle frontal 20,440.6 (3,307.4) 17,679.1 (2,576.0) 4.9 0.028
Temporal pole 2,572.04 (574.1) 2,178.6 (394.6) 4.8 0.030
Caudal ant. cingulate 2,450.1 (679.0) 1,943.9 (434.3) 4.8 0.030
Lateral occipital 14,206.3 (2,243.5) 12,217.8 (1,992.1) 4.8 0.031
Superior parietal 14,360.8 (2,222.5) 12,688.9 (1,956.1) 4.5 0.036
Pericalcarine 2,593.0 (602.1) 2,054.7 (417.9) 4.0 0.049
In both hemispheres, MANCOVA comparing regional brain volumes while covarying for age and total cerebral volume were significant
at Wilks’ lambda of p < 0.001 (left: F33,105 = 4.808; right: F33,105 = 3.538). Cortical regions significant at the Bonferroni’s corrected
threshold of p < 0.0016 are highlighted in bold. All cortical volumes are expressed in cubic millimeters
aCortical gray matter + white matter (i.e., cerebellum and subcortical gray matter excluded)
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Fig. 1 Distribution of cortical
reduction associated with
22q11DS plotted on the
average study-specific brain.
Percentage of volumetric
reduction is illustrated using a
scale centered at average
cerebral reduction (−12%,
green). Blue regions
demonstrate relative
preservation (i.e., less than
12% of reduction) and yellow
to red regions indicate regions
with the greatest percentage
reduction
Percentage of cortical reduction in 22q11.2DS
lateral lateral
ventral
medial medial
Right Left
0%
-10%
-20%
-5%
-15%
22q11DS and CHD, highlighted with different colors
on Fig. 2. First, in yellow regions on Fig. 2, patients
without CHD show an intermediate level of reduction
between the typically developing subjects and the most
affected patients with CHD. Second, 22q11DS patients
with normal cardiac status showed completely normal
volumes in three cortical regions that were exclusively
reduced in CHD. These regions are highlighted in red
on Fig. 2 and consist of the right middle temporal, the
left superior frontal, and the left parahippocampal gyri.
In further exploratory statistics, we conducted cor-
relational analyses between age at cardiac surgery and
cerebral volumes. Though, age at surgery was not a
significant predictor of total cerebral volume, neither in
the whole subgroup of patients with CHD (Pearson’s
correlation coefficient = −0.014, p = 0.944) nor after
excluding the outlier patient who was operated at
11 years old (Pearson’s correlation coefficient = 0.203,
p = 0.331). Similarly, no significant effect of age at
surgery was observed on regional cortical volumes in
Table 3 Statistical significance of regional cortical volume differences in the three-groups comparison
MANCOVA Post hoc (Scheffe test)
F p Ctl vs noCHD Ctl vs CHD noCHD vs CHD
Cerebrum 31.5 <0.001 0.009 <0.001 0.001
Left Precuneus 13.4 <0.001 <0.001 <0.001 0.031
Lateral orbitofrontal 10.8 <0.001 0.278 0.036 0.003
Fusiform 7.6 0.001 <0.001 <0.001 0.120
Rostral ant. cingulate 5.9 0.003 <0.001 <0.001 0.165
Cuneus 4.8 0.010 0.001 <0.001 0.097
Parahippocampal 4.7 0.010 0.399 <0.001 0.001
Superior parietal 3.9 0.022 0.010 <0.001 0.037
Superior frontal 3.4 0.035 0.978 <0.001 0.001
Precentral 3.3 0.041 0.075 0.037 0.077
Right Precuneus 10.3 <0.001 <0.001 <0.001 0.012
Precentral 7.7 0.001 0.419 0.011 0.002
Superior frontal 6.5 0.002 0.720 0.008 0.006
Rostral ant. cingulate 6.5 0.002 0.001 <0.001 0.033
Lateral orbitofrontal 6.4 0.002 0.994 0.013 0.046
Fusiform 6.2 0.003 0.002 <0.001 0.001
Lingual 5.5 0.005 0.001 <0.001 0.089
Superior parietal 3.1 0.049 0.030 <0.001 0.012
Middle temporal 3.1 0.050 0.967 <0.001 0.002
Cortical regions that showed significant difference in the three-condition fixed-factor MANCOVA were further tested for differences
2 × 2 using a Scheffe test on the cortical volumes residualized for age. The whole MANCOVA was highly significant in both
hemispheres (left: F62,196 = 2.803; right: F62,196 = 2.268). The most significant regions (p < 0.0016) are highlighted in bold and further
illustrated in Fig. 2
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Differences in total and regional cerebral volumes related to CHD
Fig. 2 Total and regional volumetric differences related to CHD.
Patients with 22q11DS and CHD showed more drastic reductions
in total brain volume than patients without CHD, compared
to typically developing individuals. The regional distribution of
the most significant parcels driving average cerebral reduction
is also shown: yellow regions demonstrate areas where patients
with normal cardiac status show intermediate reductions between
normal controls and patients with CHD; red depicts regions
where reduction is exclusively related to the presence of CHD
the 31 parcels (after excluding the outlier, right hemi-
sphere: p = 0.792, left hemisphere: p = 0.492).
Finally, using palate or pharyngeal surgery as the
fixed factor, we did not evidence any difference in
total (p = 0.731) or regional cerebral volumes (right
hemisphere: p = 0.771, left hemisphere: p = 0.737).
Discussion
In the present study, we used an accurate method
for measuring regional volumes over the cortex in
22q11DS with the specific aim of quantifying the effect
of CHD on brain development in the syndrome. In the
entire cohort of patients with 22q11DS, independent of
their cardiac status, we were able to replicate previous
volumetric results that used other methods (Eliez et al.
2000; Kates et al. 2001; Simon et al. 2005; Kates et al.
2004; Campbell et al. 2006). In summary, the 12.4% re-
duction of the cerebrum observed here is in accordance
with previous measurements (Eliez et al. 2000; Kates
et al. 2001). Further, thanks to the increased precision
allowed by maps of continuous volumetric changes over
the cortex, we were able to confirm the rostrocaudal
gradient in brain alterations that has been previously
suggested using techniques with poorer spatial resolu-
tion. Indeed, as noted by Gothelf et al. (2008), a more
important reduction of caudal structures was evidenced
at the lobar level (Eliez et al. 2000; Kates et al. 2001;
Simon et al. 2005), as well as in specific regions of inter-
ests such as basal ganglia (Kates et al. 2004; Campbell
et al. 2006; Eliez et al. 2002), the thalamus (Bish et al.
2004), the corpus callosum (Machado et al. 2007), and
the fusiform gyrus (Glaser et al. 2007). Turning to
potential implications of the rostrocaudal gradient of
brain alterations, several authors have pointed out that
frontal preservation may help to protect verbal per-
formances in children with 22q11DS, while posterior
reduction may alter arithmetic and visuospatial skills
(Eliez et al. 2000; Simon et al. 2005; Kates et al. 2004;
Campbell et al. 2006).
In addition to a rostrocaudal gradient, the precision
brought by the continuous measurement over the
three-dimensional cortical surface also demonstrates a
previously unreported lateromedial gradient of brain
alterations in 22q11DS. As a result of the rostrocaudal
and lateromedial gradients, we observe that the
regional distribution of cortical reductions on Fig. 2
is proximal to the territory supplied by the posterior
cerebral artery. The posterior cerebral artery supplies
the brain stem, cerebellum, caudal part of the thalamus,
and striatum and the uncus, fusiform gyrus, inferior
temporal gyrus, pericalcarine region, cuneus, lingual
gyrus, precuneus, and the occipital pole at the cortical
level (see also Fig. 3, adapted from an article by van der
Zwan and Hillen 1991). Given that various vascular
anomalies are commonly associated with 22q11DS,
Shprintzen (2000) has suggested that abnormal brain de-
velopment in the syndrome may be caused by reduced
perfusion related to cerebrovascular malformations.
J Neurodevelop Disord (2010) 2:224–234 231
a
c
b
d
Fig. 3 Variability in the arterial territories (adapted from the
article by van der Zwan and Hillen 1991). Territories supplied
by the anterior (white), middle (black), and posterior (gray) cere-
bral are schematically reproduced, illustrating possible variations
(from a to d)
However, we were missing empirical support for this hy-
pothesis. Only one study reported cerebral angiography
in the syndrome (Chow et al. 1999), observing up to
55% of minor vascular anomalies. Despite this angiog-
raphic study included a small number of subjects,
Chow and colleagues reported an increased incidence
of hypoplasia of the (right) posterior cerebral artery.
Based on Shprintzen’s original hypothesis and on the
angiographic observations by Chow et al., we speculate
that the cortical reductions observed here point to
reduced blood flow in the territory of the posterior
cerebral artery, possibly altering cerebral growth in
these regions. The observation that non-cortical regions
supplied by this artery are also reduced corroborates
this hypothesis (namely the brain stem (Eliez et al.
2001), cerebellum (Eliez et al. 2001; Bish et al. 2006),
caudal part of the thalamus (Bish et al. 2004), and
caudal part of the corpus callosum (Machado et al.
2007; Antshel et al. 2005)). The potential implications
of reduced blood supply over the territory of the
posterior cerebral artery opens avenues for more
detailed exploration of cerebrovascular anomalies in
the syndrome.
A vascular hypothesis of cerebral alterations in the
syndrome is even more likely given the regional dis-
tribution of reduced cortical volumes in the group of
patients with CHD. Among regions exclusively affected
in presence of congenital heart disease are the (left)
superior frontal gyrus and the (right) middle tempo-
ral gyrus. Again, these differences may be analyzed
in light of the arterial supply territories. As depicted
in Fig. 3, variability in arterial territories is relatively
high. However, the superior frontal and the middle
temporal gyri are the only two gyri for which their
entire length is located at the junction between two
arterial territories (namely between the anterior and
middle cerebral arteries for the middle frontal gyrus,
and between the anterior and the posterior arteries for
the middle temporal gyrus). Decades of neurological
observations have taught us that these regions, known
as watershed areas, are the first to suffer with reduced
perfusion pressure in the brain (Liu et al. 2001; Chao
et al. 2006). We can thus speculate that hypoperfusion
related to CHD has particularly impaired brain growth
in the superior frontal and middle temporal gyri.
Finally, we also observed a specific reduction of
the left parahippocampal region associated with CHD.
While a direct association between this region and
arterial territories is less straightforward, this finding
becomes interesting in light of the known vulnerability
of this region to a variety of stressful events. Indeed,
the hippocampus (a non-cortical region which was not
measured in the present study, but which is known
to be reduced in the syndrome: Debbané et al. 2006;
Deboer et al. 2007; Kates et al. 2006) is a structure
known to be highly sensitive to anoxia (Di Paola et al.
2008; Jourdain et al. 2002) or to diverse kind of stress
(Bremner et al. 1995; McEwen 1999; Sapolsky 2000).
It is possible that the nearby parahippocampal region
is similarly sensitive to stress related to CHD or to
surgery on the post-natal developing brain.
We argue that the absence of cerebral repercussions
of the other core malformations associated with the
syndrome, namely palate or pharyngeal malformations,
as well as the above-mentioned reasons, both support
a specific role for hemodynamic factors in reduced
cortical volumes in patients with CHD. Though, alter-
native explanations also need to be considered. Indeed,
the association between CHD and the observed cere-
bral anomalies may be a co-occurrence rather than a
causative effect. Common embryologic origins of the
malformed heart and brain could be incriminated. For
instance, abnormal migration of cells of the neural
crest is thought to be partially responsible for heart
anomalies in 22q11DS (Scambler 2000) and may also
be a good candidate for certain brain alterations.
The present study opens avenues for furthering our
understanding of the pathophysiology of brain alter-
ations in 22q11DS and related to CHD. However, the
establishment of a clear relationship between hemody-
namic status and the observed volumetric reductions
remains impaired by some limitations. First, cardiac
defects are largely incomparable in terms of hemo-
dynamic disturbance, and unfortunately, the present
sample size does not allow extensive explorations of the
effect of specific cardiac malformations on brain struc-
ture. Second, information about cardiac status was ob-
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tained retrospectively from cardiologists, at the time of
the patients evaluation in our research program. In the
present sample, surgical procedures were performed in
different hospitals in Switzerland or in France between
1971 and 1996. As a result, measures which would have
been interesting to correlate with brain volumes, such
as for instance oxymetry, were not available. Finally,
due to the lack of angiographic data, we were not able
to confirm a clear association between cerebrovascular
malformations and cerebral reductions. Accordingly,
recommendations for future studies in the syndrome
include (1) a precise data collection about cardiac his-
tory in all patients with 22q11DS and (2), if possible,
the acquisition of angiographic exams (e.g., magnetic
resonance angiography) jointly with other structural
MRI acquisitions.
Whatever the cause of the additional volumetric
alterations in patients with CHD, the findings of the
current study point to potential cognitive repercus-
sions. For instance, we observed that a significantly
larger proportion of low performing patients were
found in the CHD than in the noCHD subgroups. We
also observed that none of the adults with 22q11DS
who underwent cardiac surgery were included in the
high-performing subgroup of patients. If we expected
stronger cognitive differences, there may be several
explanations for the absence of a clearer association
between performances and CHD in the present study.
First, heterogeneity of CHD and surgical procedures in
the CHD subgroup may explain a lack of clear differ-
ences in cognitive performances in patients with and
without CHD. Indeed, different CHD (Limperopoulos
et al. 1999), different surgeries (Bellinger et al. 1995), or
different ages at surgery (Newburger et al. 1984) have
all been identified as important determinants of cogni-
tive outcome. Second, it is possible that the effect of
CHD on cognitive outcome, as we are able to measure
it, may remain subtle in this genetic syndrome which
is already associated with a consequent mental delay
(i.e., without CHD). Even if we identified specific vol-
umetric alterations related to CHD, these alterations
may not be directly translated into isolated cognitive
deficits. Similarly, Bellinger (2003) has discussed how
pediatric cardiac surgery differs from adult surgery,
pointing out that one occurs in a developmental and
plastic setting, whereas the other is more likely to result
in “static neuropsychological deficits”. Finally, the lack
of clear relationship between CHD and intelligence in
the entire sample of patient contrasts the difference in
cognitive performances observed between adults with
and without CHD. As Bellinger (2003) suggested, some
deficits may remain silent until the child learns more
complex tasks or, more optimistically, the difference
between children and adults’ outcomes may rely on
evolution in cardiac surgical procedures during the last
decade.
Conclusion
In the present study, we propose that the distribution of
reduced cortical volumes supports an impact of hemo-
dynamic alterations both in 22q11DS and in CHD,
opening avenues for exploring cerebrovascular malfor-
mations and their relationship with cognitive outcome
in the syndrome. First, we evidenced a rostrocaudal
and a lateromedial gradient of cortical reduction in
22q11DS, which may support a role for reduced blood
supply in the territory supplied by the posterior cere-
bral artery. Second, this study is also the first to report
changes to regional cortical volume related to CHD.
Even if these changes occur within the wider context
of the syndrome, we argue that they provide clues for
furthering our understanding of the neurology of CHD
and of the intellectual impairments often reported in
children who underwent cardiac surgery.
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